aTyr Pharma Inc
NASDAQ:ATYR

Watchlist Manager
aTyr Pharma Inc Logo
aTyr Pharma Inc
NASDAQ:ATYR
Watchlist
Price: 3.91 USD -1.51%
Market Cap: 328.2m USD
Have any thoughts about
aTyr Pharma Inc?
Write Note

P/FCFE
Price to FCFE

-4.8
Current
-4.4
Median
23.3
Industry
Lower than median
Lower than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
-4.8
=
Market Cap
328.2m USD
/
FCFE
-67.7m USD
All Countries
Close
Market Cap P/FCFE
US
aTyr Pharma Inc
NASDAQ:ATYR
328.2m USD -4.8
FR
Pharnext SCA
OTC:PNEXF
6T USD -3 238 155.5
US
Abbvie Inc
NYSE:ABBV
315.6B USD 12.7
US
Amgen Inc
NASDAQ:AMGN
140.4B USD 23.8
US
Gilead Sciences Inc
NASDAQ:GILD
113.3B USD 11.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.2B USD -79.3
US
Epizyme Inc
F:EPE
94.1B EUR -423.8
AU
CSL Ltd
ASX:CSL
138.1B AUD 78.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.2B USD 24.1
US
Seagen Inc
F:SGT
39.3B EUR -58.3
NL
argenx SE
XBRU:ARGX
37.3B EUR -117.3
 
US
aTyr Pharma Inc
NASDAQ:ATYR
Average P/FCFE: 30
Negative Multiple: -4.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -3 238 155.5
US
Abbvie Inc
NYSE:ABBV
12.7
US
Amgen Inc
NASDAQ:AMGN
23.8
US
Gilead Sciences Inc
NASDAQ:GILD
11.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -79.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -423.8
AU
CSL Ltd
ASX:CSL
78.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
24.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.3
NL
argenx SE
XBRU:ARGX
Negative Multiple: -117.3

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A